Selektive Hemmung des Endothelin-A-Rezeptors (ETAR) reduziert die Hypoxie-induzierte Invasivität von Brustkrebszellen

  • M Smollich, M Götte, C Kersting, J Fischgräbe, I Radke, L Kiesel, P Wülfing
  • Geburtshilfe und Frauenheilkunde, April 2007, Thieme Publishing Group
  • DOI: 10.1055/s-2007-983675

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1055/s-2007-983675

The following have contributed to this page: Professor Martin Götte